Iridex (IRIX) Interest Expenses (2012 - 2013)
Iridex's quarterly Interest Expenses came in at $171000.0 in Q4 2013, up 850.0% year-on-year from $18000.0 in Q4 2012, and up 101.18% quarter-over-quarter from $85000.0 in Q3 2013.
Iridex has reported Interest Expenses for 2 years, with the latest figure at $171000.0 in Q4 2013.
- For the quarter ending Q4 2013, Interest Expenses rose 850.0% year-over-year to $171000.0; the trailing twelve-month figure through Sep 2014 stood at $171000.0 (down 14.5% YoY), and the FY2013 full-year result was $371000.0, up 76.67% from the prior year.
- Interest Expenses for Q4 2013 stood at $171000.0, up from $85000.0 in the prior quarter.
- The five-year high for Interest Expenses was $171000.0 in Q4 2013, with the low at $18000.0 in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2013 | 171,000.00 |
| Dec 28, 2013 | 171,000.00 |
| Sep 28, 2013 | 85,000.00 |
| Sep 28, 2013 | 85,000.00 |
| Jun 29, 2013 | 97,000.00 |
| Jun 29, 2013 | 97,000.00 |
| Dec 29, 2012 | 18,000.00 |
| Dec 29, 2012 | 18,000.00 |
| Sep 29, 2012 | 117,000.00 |
| Sep 29, 2012 | 117,000.00 |
| Jun 30, 2012 | 48,000.00 |
| Jun 30, 2012 | 48,000.00 |